Project Grant R56AR084847
Award Date 6/22/26
Completion Date 5/31/27
Dollars Obligated $387K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
- Federal Project Grant Award Summary The Ohio State University received a $303,082 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026, with an ultimate completion date of January 31, 2030. This award supports basic biomedical research investigating mast cell-specific signaling mechanisms in wound healing and scar formation. The research will elucidate a novel...
- Federal Project Grant Award Summary The Ohio State University Office of Sponsored Programs received a $433,125 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2026, with completion targeted for January 31, 2031. The award supports investigator-initiated research to understand metabolic reprogramming in reparative macrophages and its relationship to epigenetic...
- Federal Grant Award Summary The Ohio State University received a $153,169 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), awarded on August 15, 2025, with a completion date of July 31, 2027. This research initiative develops a rapid, non-invasive triage method using Raman spectroscopy and artificial intelligence to assess radiation exposure in mass casualty scenarios resulting from nuclear reactor...
- Federal Project Grant Award Summary The Ohio State University received a $410,893 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded March 1, 2026, with completion targeted for December 31, 2030. This award supports research to discover and characterize phosphonic acid natural products (NPs) through genomics-accelerated approaches. The project aims to establish fundamental genetic,...
- Federal Grant Award Summary The Ohio State University Office of Sponsored Programs received a $1.4 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2026, with completion targeted for May 31, 2030. The award funds research focused on enhancing chemotherapy response and reducing toxicity through microbiome and immune modulation. This research addresses Service Member health and medical advancement...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Ohio State University a Project Grant of $433,125 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct basic research on influenza A virus (IAV) pathogenesis and acute respiratory distress syndrome (ARDS) mechanisms. The two-year research initiative, awarded July 2, 2025, and extending through June 30, 2027, investigates how the viral PB1-F2 protein...
- Federal Project Grant Award Summary The Ohio State University received a $159,075 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), effective August 1, 2025, through July 31, 2027. The award funds the validation of the MIRAD (Micro-RNA Assay for Radiation Dosimetry) assay as a rapid biodosimetry tool for radiological and nuclear mass casualty triage applications in pediatric and geriatric...
- Federal Grant Award Summary The Ohio State University received a $433,125 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 1, 2026, with completion targeted for June 30, 2028. The project delivers a comprehensive subcellular proteome dataset mapping protein responses to influenza infection in intact human lung tissue. The research employs a novel promiscuous biotin-ligase...
- Federal Grant Award Summary Michigan State University's Henry Ford Health+Michigan State University Health Sciences partnership received a $1,403,056 Project Grant from the National Institutes of Health Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) awarded on April 23, 2026, with a completion date of April 22, 2029. This research initiative will identify the mechanisms of acute and long-term lung toxicity resulting from dermal exposure to vesicating chemical...
- Federal Grant Award Summary Fesariustherapeutics Inc. received a $349,892 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2027. The award supports development of DermisphereShield, an antimicrobial dermal regeneration template designed to address complex wound healing challenges in contaminated environments. The product targets critical clinical...